stockrow
Friday 6 November 2026
Export SRTS’s income statement to Excel — free account
Sensus Healthcare, Inc.
SRTS Healthcare Medical Devices
Sensus Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $27.5 million, down 34.3% from fiscal 2024.
- Revenue
- −68.7%
- EPS
- −783.3%
- Free cash flow
- −201.7%
Quarter to June 2026, against a year earlier
2.92
0.00
0.00%
Follow SRTS
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 3 | 3 | 2 | 6 | 6 | 4 | 5 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08 | 4.83 | 83.00 | 17.30 | 0.00 |
Altman Z-Score |
11.29 | 6.14 | 10.20 | 4.74 | 4.98 | 12.89 | 11.23 | 6.35 | 13.07 | 8.85 |
P/S ratio |
4.26 | 3.66 | 3.96 | 2.11 | 6.62 | 4.40 | 2.61 | 1.66 | 2.70 | 2.36 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.65 | 0.00 | 0.00 | 195.73 |
Altman Z″-Score (non-manufacturers) |
7.43 | 2.93 | 7.47 | 6.48 | 3.68 | 8.58 | 13.21 | 16.43 | 16.19 | 14.36 |
P/Operating CF |
42.34 | 94.92 | (63.30) | 124.92 | (176.21) | (66.83) | (11.49) | 15.17 | (136.49) | (29.44) |
Beneish M-Score |
(1.71) | (2.76) | (0.30) | (1.28) | (4.40) | (0.41) | 1.67 | (2.32) | (1.10) | (3.66) |
P/B ratio |
4.13 | 6.46 | 3.95 | 2.05 | 2.95 | 4.57 | 2.42 | 0.83 | 2.02 | 1.35 |
Price to Tangible BV |
4.30 | 6.77 | 4.02 | 2.08 | 3.00 | 4.60 | 2.42 | 0.83 | 2.02 | 1.35 |
EV/Sales |
3.53 | 3.31 | 3.60 | 1.75 | 5.68 | 4.08 | 2.17 | 0.95 | 2.31 | 1.77 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23.30 | 6.29 | 293.40 | 11.34 | 0.00 |
EV/Operating CF |
(61.48) | (22.28) | (11.10) | (22.70) | (125.28) | (385.59) | (68.35) | (10.81) | (116.32) | 92.31 |
EV/FCF |
(46.02) | (20.36) | (10.09) | (19.07) | (68.56) | (702.42) | 7.19 | (9.94) | (87.32) | 146.81 |
Quick Ratio |
3.99 | 3.32 | 4.73 | 4.56 | 3.85 | 4.47 | 5.56 | 8.02 | 7.10 | 5.96 |
Current Ratio |
4.58 | 3.68 | 5.30 | 5.26 | 5.18 | 5.24 | 6.92 | 11.76 | 9.64 | 9.72 |
Net Debt/EBITDA |
451.17 | 2.70 | 11.41 | 10.89 | 1.98 | (3.07) | (1.66) | (293.01) | (2.59) | 2.28 |
Debt/Assets |
0.00% | 11.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.04 | 1.09 | 1.01 | 0.78 | 0.30 | 0.90 | 1.00 | 0.44 | 0.72 | 0.48 |
Operating CF/Net income |
2.46 | 0.82 | 4.23 | 1.24 | 0.06 | (0.07) | (0.06) | (4.42) | (0.12) | (0.07) |
Capex/Depreciation |
(0.85) | (0.74) | (1.30) | (0.73) | (0.50) | 0.21 | 29.16 | (0.41) | (0.64) | (0.31) |
Interest Coverage |
(16.58) | (53.95) | (12.80) | (7.34) | (588.14) | 2,060.00 | 7,415.50 | — | — | — |
| (3.27%) | (27.53%) | (10.61%) | (6.24%) | (27.62%) | 17.34% | 65.45% | 1.00% | 12.70% | (14.85%) | |
| (2.42%) | (19.64%) | (7.77%) | (4.84%) | (21.06%) | 13.67% | 54.50% | 0.88% | 11.47% | (13.40%) | |
ROIC |
(6.02%) | (85.89%) | (11.31%) | (9.83%) | (78.10%) | 22.40% | 41.11% | (0.93%) | 14.97% | (24.76%) |
Return on Tangible Assets |
(2.56%) | (27.66%) | (7.56%) | (5.94%) | (31.54%) | 15.91% | 52.95% | 1.06% | 12.58% | (17.89%) |
Average Days of Receivables |
76.36 | 87.91 | 181.57 | 187.58 | 143.91 | 163.72 | 141.79 | 159.21 | 172.26 | 80.23 |
Research and Development Expense of Revenue |
12.32% | 26.67% | 23.69% | 23.54% | 43.42% | 12.71% | 7.77% | 15.07% | 10.08% | 28.30% |
Selling, General and Administrative Expense of Revenue |
56.61% | 58.42% | 47.89% | 48.08% | 97.37% | 34.88% | 25.46% | 44.11% | 29.00% | 52.38% |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
4.90% | 1.97% | 3.72% | 2.28% | 4.03% | 1.53% | 0.42% | 1.34% | 0.77% | 1.07% |
Graham Net Nets |
0.21 | 0.14 | 0.24 | 0.44 | 0.29 | 0.21 | 0.38 | 1.10 | 0.45 | 0.63 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.92 | 9.79 | 1.42 | 5.55 | 0.00 |
Earnings Yield |
(0.61%) | (4.91%) | (1.89%) | (2.91%) | (10.88%) | 3.32% | 20.71% | 1.20% | 5.78% | (11.81%) |
Free Cash Flow Yield |
(1.80%) | (4.43%) | (9.00%) | (4.36%) | (1.25%) | (0.13%) | 11.56% | (5.76%) | (0.98%) | 0.51% |
Revenue per Share |
1.23 | 1.56 | 1.87 | 1.68 | 0.58 | 1.64 | 2.70 | 1.50 | 2.56 | 1.68 |
Operating CF per Share |
(0.07) | (0.23) | (0.61) | (0.13) | (0.03) | (0.02) | (0.09) | (0.13) | (0.05) | 0.03 |
Capex per Share |
(0.02) | (0.02) | (0.06) | (0.02) | (0.02) | 0.01 | 0.90 | (0.01) | (0.02) | (0.01) |
Free Cash Flow per Share |
(0.09) | (0.25) | (0.67) | (0.15) | (0.05) | (0.01) | 0.81 | (0.14) | (0.07) | 0.02 |
Cash per Share |
0.96 | 0.85 | 1.09 | 0.95 | 0.91 | 0.88 | 1.55 | 1.42 | 1.35 | 1.35 |
Shareholders Equity per Share |
1.27 | 0.88 | 1.87 | 1.73 | 1.31 | 1.58 | 2.92 | 3.00 | 3.42 | 2.95 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.27 | 0.88 | 1.87 | 1.73 | 1.31 | 1.58 | 2.92 | 3.00 | 3.42 | 2.95 |
Free Cash Flow |
(1.14) | (3.34) | (9.42) | (2.51) | (0.79) | (0.16) | 13.43 | (2.33) | (1.11) | 0.33 |
Working Capital |
13.10 | 13.02 | 25.88 | 27.53 | 20.32 | 25.28 | 45.54 | 45.32 | 50.85 | 41.17 |
Capital Expenditures |
(0.29) | (0.29) | (0.85) | (0.40) | (0.36) | 0.13 | 14.84 | (0.19) | (0.28) | (0.20) |
Net Current Asset Value |
13.09 | 10.73 | 25.11 | 25.08 | 18.66 | 25.02 | 44.58 | 44.66 | 50.40 | 40.95 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26.77 | 6.51 | 0.00 | 11.95 | 0.00 |
Capex to Sales |
0.02 | 0.01 | 0.03 | 0.01 | 0.04 | 0.00 | (0.33) | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.87 | 7.83 | 0.00 | 13.95 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.78 | 0.98 | 0.74 | 0.50 | 0.53 | 1.01 | 2.09 | 0.99 | 0.22 | 0.32 |
Cash ROIC |
(4.25%) | (13.33%) | (22.51%) | (5.76%) | (2.18%) | (0.39%) | 18.25% | (3.24%) | (1.42%) | 0.47% |
Accounts Receivable Turnover |
5.73 | 5.11 | 2.92 | 2.01 | 1.08 | 3.40 | 3.03 | 1.75 | 2.75 | 2.13 |
Accounts Payable Turnover |
1.96 | 1.99 | 2.06 | 1.95 | 1.13 | 2.90 | 3.11 | 2.49 | 4.57 | 3.83 |
Inventory Turnover |
4.41 | 5.60 | 6.80 | 4.20 | 1.17 | 3.25 | 2.59 | 0.84 | 1.23 | 1.06 |
Average Days of Payables |
203.06 | 218.74 | 198.15 | 179.73 | 242.38 | 147.32 | 135.21 | 98.54 | 101.06 | 78.14 |
Days of Inventory on Hand |
92.25 | 62.99 | 62.47 | 112.71 | 373.35 | 63.86 | 239.07 | 523.84 | 282.40 | 375.99 |
Average Receivables |
2.59 | 4.03 | 9.05 | 13.58 | 8.89 | 7.95 | 14.71 | 13.97 | 15.19 | 12.89 |
Average Payables |
2.53 | 3.42 | 4.62 | 4.97 | 3.83 | 3.47 | 4.79 | 4.16 | 3.80 | 4.08 |
Average Inventory |
1.13 | 1.21 | 1.40 | 2.31 | 3.71 | 3.09 | 5.76 | 12.30 | 14.15 | 14.76 |
Average Assets |
14.29 | 18.89 | 26.04 | 35.09 | 32.47 | 30.13 | 44.49 | 55.22 | 57.94 | 57.60 |
Average Common Equity |
10.60 | 13.48 | 19.07 | 27.23 | 24.75 | 23.76 | 37.04 | 48.46 | 52.33 | 51.96 |
Columns are period end dates